Because our data suggested that the MC SULT1E1+ subpopulation might play a key role in the malignancy of high‐grade meningiomas, we next investigated potential therapeutic strategies by inhibiting this unique subpopulation. The gene discussed is SULT1E1; the disease is meningioma.